Do we really know how many clinical trials are conducted ethically? Why research ethics committee review practices need to be strengthened and initial steps we could take to strengthen them.

Journal of Medical Ethics
Mark Yarborough

Abstract

Research Ethics Committees (RECs) play a critical gatekeeping role in clinical trials. This role is meant to ensure that only those trials that meet certain ethical thresholds proceed through their gate. Two of these thresholds are that the potential benefits of trials are reasonable in relation to risks and that trials are capable of producing a requisite amount of social value. While one ought not expect perfect execution by RECs of their gatekeeping role, one should expect routine success in it. This article reviews a range of evidence showing that substantial numbers of ethically tainted trials are receiving REC approvals. Many of the trials are early phase trials that evidence shows have benefits that may not be reasonable compared with their risks and many others are later trials that evidence shows may lack sufficient social value. The evidence pertains to such matters as methodologically inadequate preclinical studies incapable of supporting the inferences that REC members must make about the prospects for potential benefit needed to offset the risks in early phase trials and sponsorship bias that can cause improperly designed, conducted, analysed and reported later phase trials. The analysis of the evidence makes clear...Continue Reading

References

Mar 22, 1980·British Medical Journal·E Hemminki
May 20, 2000·JAMA : the Journal of the American Medical Association·E J EmanuelC Grady
May 31, 2003·BMJ : British Medical Journal·Joel LexchinOtavio Clark
Apr 6, 2005·The Journal of Law, Medicine & Ethics : a Journal of the American Society of Law, Medicine & Ethics·Trudo Lemmens
Aug 3, 2005·PLoS Medicine·John P A Ioannidis
Oct 17, 2009·Social Studies of Science·Sergio Sismondo
Jan 16, 2010·Journal of the National Cancer Institute·Jurjen J BoonstraWinand N M Dinjens
Aug 4, 2010·Annals of Internal Medicine·Florence T BourgeoisKenneth D Mandl
Mar 31, 2012·Nature·C Glenn Begley, Lee M Ellis
May 30, 2013·American Society of Clinical Oncology Educational Book·C Glenn Begley
Jul 23, 2013·PLoS Biology·Konstantinos K TsilidisJohn P A Ioannidis
Oct 4, 2013·The Journal of Law, Medicine & Ethics : a Journal of the American Society of Law, Medicine & Ethics·Donald W LightJonathan J Darrow
Feb 1, 2014·Nature·Francis S Collins, Lawrence A Tabak
Sep 6, 2014·BMC Medical Ethics·Michelle G J L HabetsAnnelien L Bredenoord
Feb 3, 2015·Kennedy Institute of Ethics Journal·Kirstin Borgerson
Mar 10, 2015·Journal of Clinical Epidemiology·Maria Elena FlaccoJohn P A Ioannidis
Jun 10, 2015·PLoS Biology·Leonard P FreedmanTimothy S Simcoe
Oct 16, 2015·Journal of Medical Ethics·Jonathan Kimmelman, Valerie Henderson
May 27, 2016·Nature·Monya Baker
Nov 30, 2016·Drug Discovery Today·Michelle G J L HabetsAnnelien L Bredenoord
Feb 6, 2017·Nature·Jonathan Kimmelman, Carole Federico
Nov 9, 2018·Journal of Translational Medicine·Pandora Pound, Merel Ritskes-Hoitinga
Jul 25, 2019·Ethics & Human Research·Phoebe FriesenMark Sheehan
Nov 14, 2019·Stroke; a Journal of Cerebral Circulation·F Daniel RamirezBenjamin Hibbert
Nov 14, 2019·Stroke; a Journal of Cerebral Circulation·Jens MinnerupWolf-Rüdiger Schäbitz
Nov 20, 2019·Ethics & Human Research·Bryan Anthony SiskEric Kodish
Apr 15, 2020·Journal of the Royal Society of Medicine·Tom Jefferson

❮ Previous
Next ❯

Citations

Jul 28, 2021·Journal of Medical Ethics·Kenneth Boyd
Sep 30, 2021·BMC Medical Ethics·Xing LiuXiaomin Wang

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

The Journal of Family Practice
J M Lenzer
The New England Journal of Medicine
P A Cohen
The New England Journal of Medicine
J S Reich
The New England Journal of Medicine
J I Hamburger
Irish Medical Journal
Finbarr Corkery
© 2022 Meta ULC. All rights reserved